HERON THERAPEUTICS, INC. /DE/ Operating Expenses
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Operating Expenses of $96.30 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2019-05-09
- HERON THERAPEUTICS, INC. /DE/ operating expenses for the quarter ending 2019-03-31 was $96.30M, a 51.52% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ operating expenses for the quarter ending 2018-12-31 was $80.16M, a 11.42% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ operating expenses for the quarter ending 2018-09-30 was $61.57M, a 23.41% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ operating expenses for the quarter ending 2018-06-30 was $56.13M, a 11.01% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ operating expenses for fiscal 2018 was $261.41M, a 16.02% increase from fiscal 2017.
- HERON THERAPEUTICS, INC. /DE/ operating expenses for fiscal 2017 was $225.32M, a 30.86% increase from fiscal 2016.
- HERON THERAPEUTICS, INC. /DE/ operating expenses for fiscal 2016 was $172.19M, a 77.66% increase from fiscal 2015.
- HERON THERAPEUTICS, INC. /DE/ operating expenses for fiscal 2015 was $96.92M, a 29.99% increase from fiscal 2014.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2019-03-31 | $96.30M 10-Q · filed 2019-05-09 | $176.46M derived: sum of 2 quarters · filed 2019-05-09 | $238.03M derived: sum of 3 quarters · filed 2019-05-09 | $294.16M derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | $80.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $141.72M derived: sum of 2 quarters · filed 2019-02-22 | $197.85M derived: sum of 3 quarters · filed 2019-02-22 | $261.41M 10-K · filed 2019-02-22 |
| 2018-09-30 | $61.57M 10-Q · filed 2018-11-07 | $117.70M derived: sum of 2 quarters · filed 2018-11-07 | $181.25M 10-Q · filed 2018-11-07 | $253.20M derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-06-30 | $56.13M 10-Q · filed 2018-08-08 | $119.69M 10-Q · filed 2018-08-08 | $191.63M derived: sum of 3 quarters · filed 2019-05-09 | $241.52M derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-03-31 | $63.56M 10-Q · filed 2019-05-09 | $135.50M derived: sum of 2 quarters · filed 2019-05-09 | $185.39M derived: sum of 3 quarters · filed 2019-05-09 | $235.95M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $71.94M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $121.83M derived: sum of 2 quarters · filed 2019-02-22 | $172.39M derived: sum of 3 quarters · filed 2019-02-22 | $225.32M 10-K · filed 2019-02-22 |
| 2017-09-30 | $49.89M 10-Q · filed 2018-11-07 | $100.45M derived: sum of 2 quarters · filed 2018-11-07 | $153.38M 10-Q · filed 2018-11-07 | $201.46M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $50.56M 10-Q · filed 2018-08-08 | $103.50M 10-Q · filed 2018-08-08 | $151.58M derived: sum of 3 quarters · filed 2019-02-22 | $199.31M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | $52.93M 10-Q · filed 2018-05-10 | $101.01M derived: sum of 2 quarters · filed 2019-02-22 | $148.75M derived: sum of 3 quarters · filed 2019-02-22 | $191.81M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | $48.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $95.82M derived: sum of 2 quarters · filed 2019-02-22 | $138.88M derived: sum of 3 quarters · filed 2019-02-22 | $172.19M 10-K · filed 2019-02-22 |
| 2016-09-30 | $47.73M 10-Q · filed 2017-11-06 | $90.80M derived: sum of 2 quarters · filed 2017-11-06 | $124.11M 10-Q · filed 2017-11-06 | $155.17M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $43.07M 10-Q · filed 2017-08-09 | $76.38M 10-Q · filed 2017-08-09 | $107.44M derived: sum of 3 quarters · filed 2018-02-27 | $129.93M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $33.31M 10-Q · filed 2017-05-10 | $64.37M derived: sum of 2 quarters · filed 2018-02-27 | $86.86M derived: sum of 3 quarters · filed 2018-02-27 | $109.88M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $31.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $53.55M derived: sum of 2 quarters · filed 2018-02-27 | $76.56M derived: sum of 3 quarters · filed 2018-02-27 | $96.92M 10-K · filed 2018-02-27 |
| 2015-09-30 | $22.49M 10-Q · filed 2016-11-08 | $45.51M derived: sum of 2 quarters · filed 2016-11-08 | $65.86M 10-Q · filed 2016-11-08 | $85.36M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $23.01M 10-Q · filed 2016-08-08 | $43.37M 10-Q · filed 2016-08-08 | $62.87M derived: sum of 3 quarters · filed 2017-02-23 | $81.82M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $20.36M 10-Q · filed 2016-05-05 | $39.85M derived: sum of 2 quarters · filed 2017-02-23 | $58.81M derived: sum of 3 quarters · filed 2017-02-23 | $77.60M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $19.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $38.45M derived: sum of 2 quarters · filed 2017-02-23 | $57.24M derived: sum of 3 quarters · filed 2017-02-23 | $74.56M 10-K · filed 2017-02-23 |
| 2014-09-30 | $18.95M 10-Q · filed 2015-11-06 | $37.74M derived: sum of 2 quarters · filed 2015-11-06 | $55.07M 10-Q · filed 2015-11-06 | $68.90M derived: sum of 4 quarters · filed 2015-11-06 |
| 2014-06-30 | $18.79M 10-Q · filed 2015-08-07 | $36.11M 10-Q · filed 2015-08-07 | $49.95M derived: sum of 3 quarters · filed 2015-08-07 | $62.61M derived: sum of 4 quarters · filed 2015-08-07 |
| 2014-03-31 | $17.32M 10-Q · filed 2015-05-08 | $31.15M derived: sum of 2 quarters · filed 2015-05-08 | $43.82M derived: sum of 3 quarters · filed 2015-05-08 | $59.03M derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $13.83M 10-K · filed 2014-03-07 | $26.50M derived: sum of 2 quarters · filed 2014-11-06 | $41.70M derived: sum of 3 quarters · filed 2014-11-06 | $54.46M 10-K · filed 2016-02-19 |
| 2013-09-30 | $12.66M 10-Q · filed 2014-11-06 | $27.87M derived: sum of 2 quarters · filed 2014-11-06 | $40.63M 10-Q · filed 2014-11-06 | $49.25M derived: sum of 4 quarters · filed 2014-11-06 |
| 2013-06-30 | $15.21M 10-Q · filed 2014-08-04 | $27.96M 10-Q · filed 2014-08-04 | $36.59M derived: sum of 3 quarters · filed 2014-08-04 | $42.64M derived: sum of 4 quarters · filed 2014-08-04 |
| 2013-03-31 | $12.75M 10-Q · filed 2014-05-12 | $21.38M derived: sum of 2 quarters · filed 2014-05-12 | $27.43M derived: sum of 3 quarters · filed 2014-05-12 | $31.81M derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | $8.63M 10-K · filed 2014-03-07 | $14.68M derived: sum of 2 quarters · filed 2014-03-07 | $19.06M derived: sum of 3 quarters · filed 2014-03-07 | $23.83M 10-K · filed 2015-03-13 |
| 2012-09-30 | $6.05M 10-K · filed 2014-03-07 | $10.43M derived: sum of 2 quarters · filed 2014-03-07 | $15.20M 10-Q · filed 2013-11-12 | $19.32M derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | $4.38M 10-K · filed 2014-03-07 | $9.15M 10-Q · filed 2013-08-08 | $13.27M derived: sum of 3 quarters · filed 2014-03-07 | $17.36M derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | $4.77M 10-K · filed 2014-03-07 | $8.89M derived: sum of 2 quarters · filed 2014-03-07 | $12.98M derived: sum of 3 quarters · filed 2014-03-07 | $14.77M derived: sum of 4 quarters · filed 2014-03-07 |
| 2011-12-31 | $4.12M 10-K · filed 2013-03-01 | $8.21M derived: sum of 2 quarters · filed 2013-03-01 | $10.00M derived: sum of 3 quarters · filed 2013-03-01 | $11.71M 10-K · filed 2014-03-07 |
| 2011-09-30 | $4.09M 10-K · filed 2013-03-01 | $5.88M derived: sum of 2 quarters · filed 2013-03-01 | $7.59M 10-Q · filed 2012-11-05 | $9.50M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $1.79M 10-K · filed 2013-03-01 | $3.50M 10-Q · filed 2012-08-09 | $5.41M derived: sum of 3 quarters · filed 2013-03-01 | $7.40M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $1.71M 10-K · filed 2013-03-01 | $3.62M derived: sum of 2 quarters · filed 2013-03-01 | $5.61M derived: sum of 3 quarters · filed 2013-03-01 | $9.83M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $3.90M derived: sum of 2 quarters · filed 2013-03-01 | $8.12M derived: sum of 3 quarters · filed 2013-03-01 | $11.23M 10-K · filed 2013-03-01 |
| 2010-09-30 | $1.99M 10-Q · filed 2011-11-07 | $6.21M derived: sum of 2 quarters · filed 2011-11-07 | $9.32M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $4.22M 10-Q · filed 2011-08-08 | $7.34M 10-Q · filed 2011-08-08 | ||
| 2009-12-31 | $11.50M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |